Who owns Novozymes A/s Unspons Adr adr?
- Ticker: NVZMY
- CUSIP Number: 670108109
Tip: Access positions for across all investors
Analyze quarterly positions in Novozymes A/s Unspons with up to 7 years of data, all consolidated into one spreadsheet
Download as csvTop investors of Novozymes A/s Unspons stock
Who bought or sold Novozymes A/s Unspons Adr adr this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Rhumbline Advisers | 10k | $602k | 1% | Mar 2026 |
|
| S & Co | 4.5k | $265k | 0% | Mar 2026 |
|
| Alta Capital Management | 3.9k | $231k | 100% | Mar 2026 |
|
| GAMMA Investing | 1.5k | $90k | -33% | Mar 2026 |
|
| Sterling Capital Management | 150.00 | $8.8k | -97% | Mar 2026 |
|
| Salomon & Ludwin | 59.00 | $3.5k | -75% | Mar 2026 |
|
| Nbc Securities | 40.00 | $2.4k | 100% | Mar 2026 |
|
| Pnc Financial Services | 21.00 | $1.3k | -99% | Mar 2026 |
|
| Ameriflex Group | 14.00 | $891.000600 | -50% | Dec 2025 |
|
| TrueNorth | 13.00 | $781.999400 | -13% | Mar 2026 |
|
| Hanson & Doremus Investment Management | 1.00 | $0 | 100% | Mar 2026 |
|
Who sold out of Novozymes A/s Unspons?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Ancora Advisors | Dec 2025 | 157.00 | $10k |
| Copeland Capital Management | Dec 2025 | 49.00 | $3.1k |